With a flurry of activity on the exchanges in the last month, the question on the lips of many is which cannabis company is next for the London Stock Exchange? Following their February flotations MGC Pharmaceuticals, Kanabo, and Cellular Goods have risen by over 300%, 400%, and 140%, respectively, These mirror upward movements elsewhere in the global markets following the US Elections late last year which marks the dawning of a more liberal approach to cannabis from President Biden and the Democrats. In a step-change for the UK, in September last year that the Financial Conduct Authority announced it was easing restrictions on cannabis companies floating on the London Stock Exchange. The Second Wave The first, of this second wave, may well be Oxford Cannabinoid Technologies (OCT) – innovative, UK-based biotech working with Oxford University. Unlike the trio of predecessors, OCT will look to develop cannabinoid-based medicines by following the traditional regulatory pathway of Randomised Controlled Trials.
Peter Mccusker, Cannabis Business Executive – Cannabis and Marijuana industry news, 03/18/2021 06:30:00